Patent · US Active

CB2 receptors blocks accumulation of human hepatic myofibroblasts: a novel antifibrogenic pathway in the liver

US7906156B2 · kind B2 · utility

1Cited by

0References

5Claims

0Family size

Assignee

Institut National de la Sante et de la Recherche Medicale (INSERM) · FR

Inventors

Pascale Grenard · Briançon, FR
Boris Julien · Paris, FR
Jeanne Tran Van Nhieu · Châteauroux, FR
Ariane Mallat · Paris, FR
Sophie Lotersztajn · Paris, FR

Key dates

Filing date	Feb 26, 2009
Grant date	Mar 15, 2011
Priority date	—
Expiry date	Feb 26, 2029

Classification

Technology area (CPC A)Human Necessities
CPC primaryA61P1/16
WIPO fieldPharmaceuticals
WIPO sectorChemistry

Abstract

Methods for treating diseases of the livers mediated by CB2 receptors are described. The methods may include administering an effective amount of a cannabinoid, an agent that activates a CB2 receptor, a composition that includes a non-selective agonist of CB2 and a selective antagonist of CB1, a composition that includes an agonist of CB2 receptors, and/or a composition that includes an up-regulator of CB2 receptors to a patient who has liver fibrosis.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.